Authors: Wohlleben, G Erb, KJ

Citation: G. Wohlleben et Kj. Erb, Atopic disorders: a vaccine around the corner?, TRENDS IMMU, 22(11), 2001, pp. 618-626

Authors: Ruger, BM Erb, KJ He, Y Lane, JM Davis, PF Hasan, Q

Citation: Bm. Ruger et al., Interleukin-4 transgenic mice develop glomerulosclerosis independent of immunoglobulin deposition, EUR J IMMUN, 30(9), 2000, pp. 2698-2703

Authors: Erb, KJ Kirman, J Delahunt, B Moll, H Le Gros, G

Citation: Kj. Erb et al., Infection of mice with Mycobacterium bovis-BCG induces both Th1 and Th2 immune responses in the absence of interferon-gamma signalling, EUR CYTOKIN, 10(2), 1999, pp. 147-153

Authors: Ruger, BM Hasan, Q Erb, KJ Davis, PF

Citation: Bm. Ruger et al., Progression of renal disease in interleukin-4 transgenic mice: involvementof transforming growth factor-beta, INT J EXP P, 80(3), 1999, pp. 113-123

Authors: Erb, KJ

Citation: Kj. Erb, Atopic disorders: a default pathway in the absence of infection?, IMMUNOL TOD, 20(7), 1999, pp. 317-322

Authors: Erb, KJ Hou, S Hyland, L Kirman, J Moll, H Le Gros, G

Citation: Kj. Erb et al., Constitutive expression of interleukin 4 in vivo does not lead to the development of T helper 2 type CD8(+) T cells secreting interleukin 4 or interleukin 5, IMMUNOL LET, 68(2-3), 1999, pp. 383-390